Comparing the Diagnostic Potential of ⁶⁸Ga-Alfatide II and ¹⁸F-FDG in Differentiating Between Non–Small Cell Lung Cancer and Tuberculosis

Abstract

(68)Ga-Alfatide II is qualified for detecting NSCLC primary lesions and is superior to (18)F-FDG in distinguishing NSCLC from TB in primary lesions and suggestive lymph nodes. (68)Ga-Alfatide II is more likely to be capable of detecting brain metastasis, and (18)F-FDG is more likely to be capable of detecting liver and early-stage bone metastases.